Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Bio-Gene Technology Ltd. ( (AU:BGT) ) just unveiled an update.
Bio-Gene Technology has completed its 15th harvest and extraction of Qcide oil from its far north Queensland plantation, confirming that standardized processing continues to deliver oil meeting commercial specifications. The company’s tree improvement program is yielding superior, high-oil trees, and a newly established planting area is progressing toward an initial harvest expected in spring 2026.
The company is refining pre-treatment techniques and steam distillation equipment to boost extraction efficiency and lower production costs as it prepares for large-scale commercial supply. With restocking and expansion programs underway to increase biomass capacity, Bio-Gene aims to capture rising industry demand for natural insecticidal actives, strengthening its position in a market shifting toward botanical and biological insect control solutions.
The most recent analyst rating on (AU:BGT) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Bio-Gene Technology Ltd. stock, see the AU:BGT Stock Forecast page.
More about Bio-Gene Technology Ltd.
Bio-Gene Technology Ltd. is an Australian company developing next-generation insecticides derived from natural sources, with a focus on its Qcide oil produced from Eucalyptus cloeziana plantations in far north Queensland. The business targets growing global demand for natural insect control solutions across public health, crop protection, and consumer home and garden markets, positioning Qcide as a 100% natural, OMRI-listed botanical pesticide option.
Average Trading Volume: 104,984
Technical Sentiment Signal: Buy
Current Market Cap: A$11.29M
See more insights into BGT stock on TipRanks’ Stock Analysis page.